Eltrombopag — Medica
Thrombocytopenia in a Patient Due to Immune Checkpoint Inhibitor Therapy
Initial criteria
- tried at least one systemic corticosteroid (e.g., methylprednisolone, prednisone)
- platelet count < 50 x 10^9/L
- prescribed by or in consultation with a hematologist or oncologist
Reauthorization criteria
- according to prescriber, patient demonstrated a beneficial clinical response (e.g., increased platelet counts, maintenance of platelet counts, and/or decreased frequency of bleeding episodes)
Approval duration
6 months